Cargando…
Isoniazid-induced polyneuropathy in a tuberculosis patient – implication for individual risk stratification with genotyping?
BACKGROUND: Development of polyneuropathy (PNP) under treatment for tuberculosis (TB), including isoniazid (INH), is a highly relevant adverse drug effect. The NAT2 acetylation status is a predictor of potential toxic effects of INH. The question as to whether individual risk stratification by genot...
Autores principales: | Stettner, Mark, Steinberger, Daniela, Hartmann, Christian J, Pabst, Tatjana, Konta, Lidija, Hartung, Hans Peter, Kieseier, Bernd C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559012/ https://www.ncbi.nlm.nih.gov/pubmed/26355945 http://dx.doi.org/10.1002/brb3.326 |
Ejemplares similares
-
Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy
por: Stettner, Mark, et al.
Publicado: (2015) -
Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients
por: Toure, A., et al.
Publicado: (2016) -
Interleukin-17 impedes Schwann cell-mediated myelination
por: Stettner, Mark, et al.
Publicado: (2014) -
Correlation of N-Acetyltransferase 2 Genotype with Isoniazid Acetylation in Polish Tuberculosis Patients
por: Zabost, Anna, et al.
Publicado: (2013) -
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy
por: Klehmet, Juliane, et al.
Publicado: (2023)